Cavernous Sinus Involvement in ROCM and COVID‑19 Outcomes

Cavernous sinus involvement was seen in 48.1% of 106 ROCM cases, with mortality at 9.4%. COVID‑positive patients had a higher involvement rate (51.8%) compared with COVID‑negative (34.8%). Read more: getnews.me/cavernous-sinus-involvem... #rocm #cavernoussinus

👀Nice case of cavernous sinus syndrome: 36-year-old male with ptosis, ophthalmoplegia caused by a pituitary tumor extending into the cavernous sinus.

Read more: doi.org/10.1016/j.jo...

#NeuroTwitter #Neurology #Neurosurgery #CavernousSinus #CranialNerve #NeuroOphthalmology #PituitaryTumor